Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.

Chiang KC, Tsui KH, Chung LC, Yeh CN, Chang PL, Chen WT, Juang HH.

PLoS One. 2014 Feb 20;9(2):e89117. doi: 10.1371/journal.pone.0089117. eCollection 2014.

2.

Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.

Chiang KC, Tsui KH, Chung LC, Yeh CN, Feng TH, Chen WT, Chang PL, Chiang HY, Juang HH.

Sci Rep. 2014 Jul 1;4:5511. doi: 10.1038/srep05511.

3.

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.

Int J Cancer. 2012 Jun 15;130(12):2812-23. doi: 10.1002/ijc.26284. Epub 2011 Aug 30.

4.

L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH.

Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C676-85. doi: 10.1152/ajpcell.00180.2011. Epub 2011 Nov 23.

5.

BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.

Hu XD, Meng QH, Xu JY, Jiao Y, Ge CM, Jacob A, Wang P, Rosen EM, Fan S.

Biochem Biophys Res Commun. 2011 Jan 28;404(4):903-9. doi: 10.1016/j.bbrc.2010.12.064. Epub 2010 Dec 21.

PMID:
21172304
6.

Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.

Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH.

Prostate. 2008 May 1;68(6):610-9. doi: 10.1002/pros.20725.

PMID:
18196550
7.

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.

Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB.

Cancer Biol Ther. 2008 Aug;7(8):1288-96. Epub 2008 Aug 13.

PMID:
18497571
8.

Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.

Tsui KH, Lin YF, Chen YH, Chang PL, Juang HH.

J Androl. 2011 Jul-Aug;32(4):383-93. doi: 10.2164/jandrol.109.009878. Epub 2010 Nov 4.

PMID:
21051589
9.

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH.

J Androl. 2008 Nov-Dec;29(6):661-8. doi: 10.2164/jandrol.108.004911. Epub 2008 Jul 31.

11.

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T.

Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23.

PMID:
22266859
13.

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.

Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD.

Carcinogenesis. 2001 Aug;22(8):1271-9.

PMID:
11470758
14.

B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.

Lim YB, Park TJ, Lim IK.

J Biol Chem. 2008 Nov 28;283(48):33110-8. doi: 10.1074/jbc.M804255200. Epub 2008 Oct 7.

15.
16.

Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.

Hsu JC, Zhang J, Dev A, Wing A, Bjeldanes LF, Firestone GL.

Carcinogenesis. 2005 Nov;26(11):1896-904. Epub 2005 Jun 15.

PMID:
15958518
17.

Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.

Wang Z, Lee HJ, Wang L, Jiang C, Baek NI, Kim SH, Lü J.

Pharm Res. 2009 May;26(5):1140-8. doi: 10.1007/s11095-009-9833-2. Epub 2009 Mar 6.

PMID:
19266268
18.
19.

Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells.

Tsui KH, Chang PL, Lin HT, Juang HH.

J Urol. 2004 Nov;172(5 Pt 1):2035-9.

PMID:
15540784
20.

Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.

Horii K, Suzuki Y, Kondo Y, Akimoto M, Nishimura T, Yamabe Y, Sakaue M, Sano T, Kitagawa T, Himeno S, Imura N, Hara S.

Mol Cancer Res. 2007 Apr;5(4):383-91.

Supplemental Content

Support Center